Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Linda who wrote (903)	3/25/1998 11:41:00 AM
From: Fred Levine	Read Replies (1) \| Respond to of 1605

While having a heart attack at Stony Brook Hospital--not to miss an opportunity to promote VASO-- I asked about the potential of EECP. The ER attending, a friend, told me that they are planning research about the effectiveness of EECP in the emergency room. Stony Brook is one of the research centers for VASO. I was shocked about the lack of awareness on the part of cardiologists of EECP, which I'm sure <gg> was not motivated by financial incentives, but I did talk to friends who worked in the EECP unit. They are truly excited by its potential. My prediction is that there will be a war betwen the surgeons and the "regular" cardiologists and internists about evasive vs. non. I'll probably try it next time to clear more arteries. good investing -- fred PS--the clot dissolvers dissolved the clot before any coronary damage. This field is advancing at mechanical, sugical, and physiological levels!